While latest earnings were mixed, Real Money's Stephen 'Sarge' Guilfoyle sees this company in a strong position as companies scramble to boost data protection.

The CEO tells Jim Cramer that recurring revenue could grow five-fold.

Jim Cramer says investors need to be cautious next week as the markets' attention shifts from Ukraine back to inflation and the Fed.

Stocks ended higher Friday as investors reacted to strong economic data and Russia's attack on Ukraine.

Jefferies created lists of 10 stocks that may benefit from rising rates and 10 that may suffer.

Jim Cramer says if a company doesn't make real things and have real profits, the risk of big losses is high.

Nasdaq 19,000, Apple and Microsoft market caps above $3 trillion, and metaverse mania: Wedbush's Dan Ives and his team give their top 10 tech predictions for 2022.

Jim Cramer says investors should ignore pre-market jitters and focus on the three things the market really cares about.

Prime Medicine, a third-generation Crispr company, may test the choppy waters of the stock market with an IPO.

The e-commerce giant has just made a decision that suggests the health of the economy is not improving.

Well-known for his dislike of covid mandates, Elon Musk did not shy away from using the pandemic to reschedule his testimony.